Si-Bone Inc - Asset Resilience Ratio
Si-Bone Inc (SIBN) has an Asset Resilience Ratio of 45.35% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Si-Bone Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Si-Bone Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Si-Bone Inc assets under control.
Liquid Assets Composition Over Time
This chart breaks down Si-Bone Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Si-Bone Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $112.81 Million | 45.35% |
| Total Liquid Assets | $112.81 Million | 45.35% |
Asset Resilience Insights
- Very High Liquidity: Si-Bone Inc maintains exceptional liquid asset reserves at 45.35% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Si-Bone Inc Industry Peers by Asset Resilience Ratio
Compare Si-Bone Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Si-Bone Inc (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Si-Bone Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 44.26% | $105.58 Million | $238.56 Million | -5.69pp |
| 2024-12-31 | 49.95% | $115.09 Million | $230.44 Million | -7.66pp |
| 2023-12-31 | 57.61% | $132.75 Million | $230.43 Million | +9.01pp |
| 2022-12-31 | 48.60% | $76.57 Million | $157.55 Million | +4.74pp |
| 2021-12-31 | 43.86% | $83.56 Million | $190.51 Million | -20.16pp |
| 2020-12-31 | 64.02% | $142.85 Million | $223.14 Million | -5.50pp |
| 2019-12-31 | 69.52% | $81.34 Million | $117.01 Million | -0.58pp |
| 2018-12-31 | 70.10% | $97.10 Million | $138.52 Million | -- |
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more